Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mitjans Francesc is active.

Publication


Featured researches published by Mitjans Francesc.


Archive | 1999

MONOCLONAL ANTIBODY ANTI .ALPHA.V-INTEGRIN AND ITS USE TO INHIBIT .ALPHA.V.BETA.6-INTEGRIN ATTACHMENT TO FIBRONECTIN

Goodman Simon; Diefenbach Beate; Mitjans Francesc; Carceller Ana; Rosell-Vives Elisabet


Archive | 2017

ANTISTOFFER TIL PÅVISNINGEN AF INTEGRINKOMPLEKSER I FFPE MATERIALE

Goodman Simon; Wilm Claudia; Mitjans Francesc


Archive | 2017

Anticuerpos anti S100A7 para el tratamiento y diagnóstico de cáncer

Hernandez Miguez Jose Luis; Adan Jaume; Martinez Escolà Josep Maria; Masa Alvarez Marc; Messeguer Peypoch Ramon; Mitjans Francesc; Dakhel Sheila; Coll Manzano Antonio; Hervas Villegas Rosa Mª; Calvis Calpe Carme; Padilla Laura; Roque Navarro Lourdes Tatiana; Barberà Ferrando Laura; Rivas Canas Manuel


Archive | 2017

Anticuerpos para la detección de complejos de integrina en material FFPE

Goodman Simon; Wilm Claudia; Mitjans Francesc


Archive | 2016

anticorpos para detecção de complexos de integrina em material ffpe

Wilm Claudia; Mitjans Francesc; Goodman Simon


Archive | 2015

ANTICORPOS HÍBRIDOS ANTIALFA V-INTEGRINA PROJETADOS

Goodman Simon; Hahn Diane; Mitjans Francesc; Adan Jaume; Lo Kin-Ming


PLOS ONE | 2013

Tumorigenic study on MiaPACA-2 xenograft model silencing S100A4.

Luis Hernández Jose; Padilla Laura; Dakhel Sheila; Coll Toni; Hervas Rosa; Adan Jaume; Masa Marc; Mitjans Francesc; Maria Martinez Josep; Coma Silvia; Rodriguez Laura; Noé Véronique; J. Ciudad Carlos; Blasco Francesc; Messeguer Peypoch Ramon


Archive | 2013

Anticuerpos híbridos anti- integrina alfa V modificados genéticamente

Goodman Simon; Hahn Diane; Mitjans Francesc; Adan Jaume; Lo Kin-Ming


Archive | 2012

FREMSTILLEDE ANTI-ALFA-V-INTEGRIN HYBRID-ANTISTOFFER

Goodman Simon; Hahn Diane; Mitjans Francesc; Adan Jaume; Lo Kin-Ming


Archive | 2010

fragmento de anticorpo monoclonal bivalente, bem como composiÇço farmacÊutica compreendendo o mesmo.

Mitjans Francesc; Piulats Jaume; Rosell Elisabet; Adan Jaume; Goodman Simon; Hahn Diane

Researchain Logo
Decentralizing Knowledge